Financhill
Buy
85

DXT.TO Quote, Financials, Valuation and Earnings

Last price:
$11.84
Seasonality move :
0.88%
Day range:
$11.87 - $12.15
52-week range:
$6.88 - $12.21
Dividend yield:
3.03%
P/E ratio:
18.95x
P/S ratio:
0.74x
P/B ratio:
2.62x
Volume:
19.4K
Avg. volume:
47.8K
1-year change:
61.89%
Market cap:
$745.6M
Revenue:
$1B
EPS (TTM):
$0.63

Earnings Data

Next earnings date for DXT.TO
Mar 03
2026
Most recent earnings per share
$0.20
Missed by $0.01
(Nov 4/2025)
Consensus Estimate
$0.21
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DXT.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/03/2026 Q4 $271.4M -- -- $0.18 --
11/04/2025 Q3 $280.2M $281.2M $0.20 $0.21 -$0.01
06/30/2025 Q2 $259.4M $249.3M $0.19 $0.19 -$0.00
05/06/2025 Q1 $250.2M $239.7M $0.13 $0.14 -$0.01
12/31/2024 Q4 $254.1M $247.8M $0.11 $0.13 -$0.02
09/30/2024 Q3 $271.1M $269.7M $0.12 $0.21 -$0.09
06/30/2024 Q2 $252.2M $253.6M $0.14 $0.09 $0.05
03/31/2024 Q1 $274.1M $231.9M -$0.06 $0.07 -$0.13
12/31/2023 Q4 $270.5M $231.2M -$0.00 $0.13 -$0.14
09/30/2023 Q3 $276M $265.8M $0.21 $0.15 $0.07
06/30/2023 Q2 -- $214.7M $0.13 -- --
03/31/2023 Q1 -- $216M $0.07 -- --
12/31/2022 Q4 -- $253.9M -$0.05 -- --
09/30/2022 Q3 -- $259.8M $0.08 -- --
06/30/2022 Q2 -- $233.9M $0.00 -- --
03/31/2022 Q1 -- $224M $0.01 -- --
12/31/2021 Q4 -- $201.6M $0.06 -- --
09/30/2021 Q3 -- $202.8M $0.12 -- --
06/30/2021 Q2 -- $173.6M $0.13 -- --
03/31/2021 Q1 -- $155.4M $0.07 -- --
12/31/2020 Q4 -- $164.4M -$0.00 -- --
09/30/2020 Q3 -- $170.3M $0.24 -- --
06/30/2020 Q2 -- $76.1M $1.08 -- --
03/31/2020 Q1 -- $60.4M $0.03 -- --
12/31/2019 Q4 -- $64.1M $0.04 -- --
09/30/2019 Q3 -- $76.2M $0.10 -- --
06/30/2019 Q2 -- $66.5M $0.11 -- --
03/31/2019 Q1 -- $128.7M $0.11 -- --
12/31/2018 Q4 -- $118M $0.04 -- --
09/30/2018 Q3 -- $100M -$0.00 -- --
06/30/2018 Q2 -- $93.6M -$0.10 -- --
03/31/2018 Q1 -- $82.6M -$0.21 -- --
12/31/2017 Q4 -- $82.7M -$0.15 -- --
09/30/2017 Q3 -- $79.3M -$0.20 -- --
06/30/2017 Q2 -- $91.6M -$0.10 -- --
03/31/2017 Q1 -- $70.5M $0.20 -- --
12/31/2016 Q4 -- $60.4M -$0.25 -- --
09/30/2016 Q3 -- $60.1M -$0.20 -- --
06/30/2016 Q2 -- $52.5M -$0.30 -- --
03/31/2016 Q1 -- $77.9M -$0.01 -- --
12/31/2015 Q4 -- $68.7M -$0.20 -- --

Dexterra Group, Inc. Earnings Questions

  • How Much did Dexterra Group, Inc. Generate in Revenue Last Quarter?

    Dexterra Group, Inc. reported $281.2M worth of top line sales in its most recent quarter.

  • Did Dexterra Group, Inc. Beat Earnings Last Quarter?

    Dexterra Group, Inc. announced earnings per share of $0.20 which represents a miss of analyst forecast a $0.21 per share.

  • Is Dexterra Group, Inc. Profitable?

    Dexterra Group, Inc. reported $40.5M that represents $0.64 per share over the last quarter.

  • What is the Analyst Consensus for Dexterra Group, Inc. EPS Next Year?

    Dexterra Group, Inc.'s earnings are forecast to grow from $0.31 per share to $0.59 per share next year representing an increase of 139.48%.

  • When is Dexterra Group, Inc.'s Earnings Date?

    Dexterra Group, Inc.'s next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock